A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes

Journal of Cell Biology

Volumn 140, Issue 6, 1998, Pages 1427-1439

  Depoortere, Fabienne ^a   Van Keymeulen, Alexandra ^a   Lukas, Jiri ^b   Costagliola, Sabine ^a   Bartkova, Jirina ^b   Dumont, Jacques E ^a   Bartek, Jiri ^b   Roger, Pierre P ^a   Dremier, Sarah ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; THYROTROPIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOG; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SECOND MESSENGER; THYMOCYTE;

ANIMALS; BLOOD PROTEINS; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; CYCLIC AMP; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; DOGS; EPIDERMAL GROWTH FACTOR; EPITOPES; FLUORESCENT ANTIBODY TECHNIQUE; G1 PHASE; HYPOGLYCEMIC AGENTS; INSULIN; MITOGENS; PROTO-ONCOGENE PROTEINS; THYROID GLAND; THYROTROPIN;

EID: 0032559825     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.140.6.1427     Document Type: Article

References (76)

1. Ajchenbaum, F., K. Ando, J.A. De Caprio, and J.D. Griffin. 1993. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113-4119.
2. Baldin, V., J. Lukas, M.J. Marcotte, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
3. Baptist, M., J.E. Dumont, and P.P. Roger. 1993. Demonstration of cell cycle kinetics in thyroid primary culture hy immunostaining of proliferating cell nuclear antigen: differences in cyclic AMP-dependent and -independent mitogenic stimulations. J. Cell Sci. 105:69-80.
4. Baptist, M., J.E. Dumont, and P.P. Roger. 1995. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance hut not on MAP kinase phosphorylation and nuclear translocalion in dog thyroid epithelial cells. Exp. Cell Res. 221:160-171.
5. Baptist, M., F. Lamy, J. Gannon, T. Hunt, J.E. Dumont, and P.P. Roger. 1996. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles. J. Cell. Physiol. 166:256-273.
6. Bartek, J., J. Bartkova, and J. Lukas. 1996. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:805-814.
7. Bartkova, J., M. Zemanova, and J. Bartek. 1996. Abundance and subcellular localisation of cyclin D3 in human tumors. Int. J. Cancer. 65:323-327.
8. Beijersbergen, R.L., and R. Bernards. 1996. Cell cycle regulation hy the retinoblastoma family of growth inhihitory proteins. Biochim. Biopliys. Acta. 1287: 103-120.
9. kip1 with cyclin A-cdk2 and cyclin D2-cdk4. J. Biol. Chem. 272:25863-25872.
10. Boynton, A.L., and J.F. Whitfield. 1983. The role of cyclic AMP in cell proliferation: a critical assessment of the evidence. Adv. Cyclic Nucleotide Res. 15: 193-294.
11. Burikhanov, R., K. Coulonval, I. Pirson, F. Lamy, J.E. Dumont, and P.P. Roger. 1996. Thyrotropin via cyclic AMP induces insulin receptor expression and insulin co-stimulation of growth and amplifies insulin and insulin-like growth factor signaling pathways in dog thyroid epithelial cells. J. Biol. Chem. 271:29400-29406.
12. Christoffersen, J., E.B. Smeland, T. Stokke, K. Tasken, K.B. Anderson, and H.K. Blomhoff. 1994. Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells. Cancer Res. 54:2245-2250.
13. KIP1 for restriction point control of the fibroblast cell cycle. Science. 272: 877-880.
14. Cocks, E.G., G. Vairo, S.E. Bodrug, and J.A. Hamilton. 1992. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J. Biol. Chem. 267:12307-12310.
15. Coppëe, F., A.C. Gérard, J.F. Denef, C. Ledent, G. Vassart, J.E. Dumont, and M. Parmentier. 1996. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene. Oncogene. 13:1471-1482.
16. Coulonval, K., C. Maenhaut, J.E. Dumont, and F. Lamy. 1997. Phosphorylation of the three Rb protein family members is a common step of the cAMP-, the growth factors- and the phorbol esters-mitogenic cascades but is not necessary for the hypertrophy induced by insulin. Exp. Cell Res. 233:395-398.
17. KIP during the cAMP-dependent mitogenic stimulation of thyroid epithelial cells. J. Cell Sci. 109:1759-1764.
18. Dremier, S., V. Pohl, C. Poteet-Smith, P.P. Roger, J. Corbin, S.O. Doskeland, J.E. Dumont, and C. Maenhaut. 1997. Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells. Mol. Cell. Biol. 17:6717-6726.
19. Dumont, J.E., J.C. Jauniaux, and P.P. Roger. 1989. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem. Sci. 14:67-71.
20. Dumont, J.E., F. Lamy, P. Roger, and C. Maenhaut. 1992. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol. Rev. 72:667-697.
21. Ewen, M.E., H.K. Sluss, L.L. Whitehouse, and D.M. Livingston. 1993. TGFβ inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell. 74:1009-1020.
22. Geng, V., E. NgEaton, M. Picon, J.M. Roberts, A.S. Lundberg, A. Gifford, C. Sardet, and R.A. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene. 12:1173-1180.
23. Higashi, H., I. Suzuki-Takahashi, S. Saitoh, K. Segawa, Y. Taya, A. Okuyama, S. Nishimura, and M. Kitagawa. 1996. Cyclin-dependent kinase-2 (cdk2) forms an inactive complex with cyclin D1 since cdk2 associated with cyclin D1 is not phosphorylated by cdk7-cyclin H. Eur. J. Biochem. 237:460-467.
24. Kato, J.Y., and C.J. Sherr. 1993. Inhibition of granulocyte differentiation by G1 cyclin D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA. 90:11513-11517.
25. KIP1) of cyclin-dependent kinase 4 activation. Cell. 79:487-496.
26. Kiess, M., R.M. Gill, and P.A. Hamel. 1995. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation by myoblasts into quiescent myotubes. Oncogene. 10:159-166.
27. LaBaer, J., M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Standhu, H.S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of cdk inhibitors. Genes Dev. 11:847-862.
28. Lamy, F., F. Wilkin, M. Baptist, J. Posada, P.P. Roger, and J.E. Dumont. 1993. Phosphorylation of mitogen-activated protein kinases is involved in the epidermal growth factor and phorbol ester, but not in the thyrotropin/cAMP thyroid mitogenic pathway. J. Biol. Chem. 268:8398-8401.
29. Lahti, J.M., H. Li, and V.J. Kidd. 1997. Elimination of cyclin D1 in vertebrate cells leads to an altered cell cycle phenotype, which is rescued by overexpression of murine cyclins D1, D2, D3 but not by a mutant cyclin D1. J. Biol. Chem. 272:10859-10869.
30. L'Allemain, G., J.N. Lavoie, N. Rivard, V. Baldin, and J. Pouysségur. 1997. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene. 14:1981-1990.
31. Ledent, C., J.E. Dumont, G. Vassart, and M. Parmentier. 1992. Thyroid expression of an A2 adenosine receptor transgene induces hyperplasia and hyperthyroidism. EMBO (Eur. Mol. Biol. Organ.) J. 11:537-542.
32. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene. 9:707-718.
33. Lukas, J., J. Bartkova, M. Ronde, M. Strauss, and J. Bartek. 1995a. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
34. Lukas, J., J. Bartkova, M. Welcker, O.W. Petersen, G. Peters, M. Strauss, and J. Bartek. 1995b. Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene. 10:2125-2134.
35. Lukas, J., D. Parry, L. Aagaard, D.J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995c. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature. 375:503-506.
36. INK4A-mediated growth suppression. Mol. Cell. Biol. 16:1047-1057.
37. Lukas, J., J. Bartkova, and J. Bartek. 1996b. Convergence of mitogenic cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol. Cell. Biol. 16:6917-6925.
38. Lukas, J., T. Heranger, K. Hansen, M.C. Moroni, D. Resnitzki, K. Helin, S.I. Reed, and J. Bartek. 1997. Cyclin E - induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479-1492.
39. Lyons, J., C.A. Landis, L. Harsh, K. Vallar, H. Grünewald, H. Feichtinger, Q.Y. Duh, O.H. Clark, E. Kawasaki, H.R. Bourne, and F. McCormick. 1990. Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
40. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
41. ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA. 92:6289-6293.
42. Meyerson, M., and E. Harlow. 1994. Identification of G1 kinase activity for cdk6a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
43. Musgrove, F.A., J.A. Hamilton, C.S.L. Lee, K.J.F. Sweeney, C.K.W. Watts, and R.L. Sutherland. 1993. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13:3577-3587.
44. Ohtani, K.J., J. Degregori, and J.R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA. 92:12146-12150.
45. Ohtsubo, M., A.M. Theodoras, J. Schumacher, J.M. Roberts, and M. Pagano, 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
46. Parma, J., L. Duprez, J. Van Sande, P. Cochaux, C. Gervy, J. Mockel, J.E. Dumont, and G. Vassart. 1993. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
47. Pirson, I., K. Coulonval, F. Lamy, and J.F., Dumont. 1996. c-myc expression is controlled by the mitogenic cAMP-cascade in thyrocytes. J. Cell. Physiol. 168:59-70.
48. Pohl, V., P.P. Roger, D. Christophe, G. Pattyn, G. Vassart, and J.E. Dumont. 1990. Differentiation expression during proliferative activity induced through different pathways: in situ hybridization study of thyroglobulin gene in thyroid epithelial cells. J. Cell Biol. 111:663-672.
49. Quelle, D.E., R.A. Ashmun, S.A. Shurtleff, J.Y. Kato, M.F. Bar-Sagi, M.F. Roussel, and C.J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
50. Rao, S.S., and D.S. Kohtz. 1995. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270:4093-4100.
51. Ravnik, S.E., K. Rhee, and D.J. Wolgemuth. 1995. Distinct patterns of expression of D-type cyclins during testicular development in the mouse. Dev Genet. 16:171-178.
52. Reed, S.I. 1991. G1-specific cyclins: in search of an S-phase-promoting factor. Trends Genet. 7:95-99.
53. Resnitzky, D., and S.I. Reed. 1995. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol. 15:3463-3469.
54. Reuse, S., I. Pirson, and J.E. Dumont. 1991. Differential regulation of protooncogenes c-jun and jun D expressions by protein tyrosine kinase, protein kinase C, and cyclic AMP mitogenic pathways in dog primary thyrocytes: TSH and cyclic AMP induce proliferation but downregulate c-jun expression Exp. Cell Res. 196:210-215.
55. kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev. 11:492-503.
56. Rock, C.O., J.L. Cleveland, and S. Jackowski. 1992. Macrophage growth arrest by cyclic AMP defines a distinct checkpoint in the mid G1 stage of the cell cycle and overrides constitutive c-myc expression. Mol. Cell. Biol. 12:2351-2358.
57. Roger, P.P., P. Servais, and J.E. Dumont. 1983. Stimulation by thyrotropin and cyclic AMP of the proliferation of quiescent canine thyroid cells cultured in a defined medium containing insulin. FEBS Lett. 157:323-327.
58. Roger, P.P., P. Servais, and J.E. Dumont. 1987a. Regulation of dog thyroid epithelial cell cycle by forskolin, an adenylate cyclase activator. Exp. Cell Res. 172:282-292.
59. Roger, P.P., P. Servais, and J.E. Dumont. 1987b. Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin. J. Cell. Physiol. 130:58-67.
60. Roger, P.P., M. Baptist, and J.E. Dumont. 1992. A mechanism generating heterogeneity in thyroid epithelial cells: suppression of the thyrotropin/cAMP-dependent mitogenic pathway after cell division induced by cAMP-independent factors. J. Cell Biol. 117:383-393.
61. Roger, P.P., S. Reuse, C. Maenhaut, and J.E. Dumont. 1995. Multiple facets of the modulation of growth by cAMP. Vitam. Horm. 51:59-191.
62. Roger, P.P., D. Christophe, J.E. Dumont, and I. Pirson. 1997. The dog thyroid culture system: a model of regulation of function, growth and differentiation expression by cAMP and other well defined signaling cascades. Eur. J. Endocrinol. 137:579-598.
63. Sewing, A.S.B., C. Burger, C. Shalk, F.C. Lucibello, and R. Müller. 1993. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104:545-555.
64. Sherr, C.J. 1993. Mammalian G1 cyclins. Cell. 73:1059-1065.
65. Sherr, C.J. 1994. G1 phase progression: cycling on cue. Cell. 79:551-555.
66. Sherr, C.J. 1996. Cancer cell cycles. Science. 274:1672-1677.
67. Sicinski, P., J.L. Donaher, S.B. Parker, T. Li, A. Fazelli, H. Gartner, S.Z. Haslam, R.T. Bronson, S.J. Elledge, and R.A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:621-630.
68. Sicinski, P., J.L. Donaher, Y. Geng, S.B. Parker, H. Gardner, M.Y. Park, R.L. Robker, J.S. Richards, L.K. McGimis, J.D. Biggers, et al. 1996. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 384:470-474.
69. Soos, T.J., H. Kiyokawa, J.S. Yan, M.S. Rutin, A. Giordano, A. De Blasio, S. Bottega, B. Wong, J. Mendelson, and A. Koff. 1996. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ. 7:135-146.
70. Tam, S.W., A.M. Theodoras, J.W. Shay, G.F. Draetta, and M. Pagano. 1994. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1 progression. Oncogene. 9:2663-2674.
71. Vintermyr, O.K., G.M. Mellgren, R. Boe, and S.O. Doskeland. 1989. Cyclic adenosine monophosphate acts synergistically with dexamethasone to inhibit entrance of culture rat hepatocytes into S phase. J. Cell. Physiol. 141:371-382.
72. Wang, Z., Y. Zhang, D. Kamen, E. Lees, and K. Ravid. 1995. Cyclin D3 is essential for megakaryocytopoiesis. Blood. 86:3783-3788.
73. KIP1 in G-CSF-treated NFS-60 cells. Biochem. Biophys. Res. Commun. 224:10-16.
74. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-330.
75. Xiona, Y., M. Zhang, and D. Beach. 1992. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:505-514.
76. Yamamoto, K., A. Hisai, T. Ban, J. Saito, K. Tahara, T. Terano, Y. Tamura, Y. Saito, and M. Kitagawa. 1996. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells. Endocrinology. 137:2036-2042.